Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The effect of chromosome 9p21 variants on cardiovascular disease may be modified by dietary intake: evidence from a case/control and a prospective study.
Do R, Xie C, Zhang X, Männistö S, Harald K, Islam S, Bailey SD, Rangarajan S, McQueen MJ, Diaz R, Lisheng L, Wang X, Silander K, Peltonen L, Yusuf S, Salomaa V, Engert JC, Anand SS; INTERHEART investigators. Do R, et al. PLoS Med. 2011 Oct;8(10):e1001106. doi: 10.1371/journal.pmed.1001106. Epub 2011 Oct 11. PLoS Med. 2011. PMID: 22022235 Free PMC article.
An evidence based clinical aid for cardiovascular disease--what do GPs think?
Mcavoy BR, Fulcher GR, Amerena JV, Conner GW, Beltrame JF, Hankey GJ, Keech AC, Lloyd BL, Neale ML, Pollock CA, Sudhir K, Waltham RD, West MJ; Practical Implementation Taskforce for the Prevention of Cardiovascular Disease. Mcavoy BR, et al. Among authors: amerena jv. Aust Fam Physician. 2005 Apr;34(4):297-8. Aust Fam Physician. 2005. PMID: 15861759 No abstract available.
Prevention of cardiovascular disease: an evidence-based clinical aid.
Fulcher GR, Conner GW, Amerena JV; Practical Implementation Taskforce for the Prevention of Cardiovascular Disease. Fulcher GR, et al. Among authors: amerena jv. Med J Aust. 2003 Jul 21:1-14. doi: 10.5694/j.1326-5377.2004.tb06318.x. Med J Aust. 2003. PMID: 13677692 No abstract available.
Stellate ganglion block from a different perspective.
Amerena JV, Schweitzer SA. Amerena JV, et al. Med J Aust. 1989 Oct 2;151(7):421. doi: 10.5694/j.1326-5377.1989.tb101240.x. Med J Aust. 1989. PMID: 2796821 No abstract available.
Icosapent Ethyl Reduces Ischemic Events in Patients With a History of Previous Coronary Artery Bypass Grafting: REDUCE-IT CABG.
Verma S, Bhatt DL, Steg PG, Miller M, Brinton EA, Jacobson TA, Dhingra NK, Ketchum SB, Juliano RA, Jiao L, Doyle RT Jr, Granowitz C, Gibson CM, Pinto D, Giugliano RP, Budoff MJ, Mason RP, Tardif JC, Ballantyne CM; REDUCE-IT Investigators. Verma S, et al. Circulation. 2021 Dec 7;144(23):1845-1855. doi: 10.1161/CIRCULATIONAHA.121.056290. Epub 2021 Oct 28. Circulation. 2021. PMID: 34710343 Free article. Clinical Trial.
Combating Inflammation in Cardiovascular Disease.
Sethwala AM, Goh I, Amerena JV. Sethwala AM, et al. Among authors: amerena jv. Heart Lung Circ. 2021 Feb;30(2):197-206. doi: 10.1016/j.hlc.2020.09.003. Epub 2020 Oct 8. Heart Lung Circ. 2021. PMID: 33039279 Review.
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia.
Bhatt DL, Steg PG, Miller M, Brinton EA, Jacobson TA, Ketchum SB, Doyle RT Jr, Juliano RA, Jiao L, Granowitz C, Tardif JC, Ballantyne CM; REDUCE-IT Investigators. Bhatt DL, et al. N Engl J Med. 2019 Jan 3;380(1):11-22. doi: 10.1056/NEJMoa1812792. Epub 2018 Nov 10. N Engl J Med. 2019. PMID: 30415628 Clinical Trial.
27 results